Cargando…

Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1

The remarkable heterogeneity of glioblastoma, across patients and over time, is one of the main challenges in precision diagnostics and treatment planning. Non-invasive in vivo characterization of this heterogeneity using imaging could assist in understanding disease subtypes, as well as in risk-str...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rathore, Saima, Akbari, Hamed, Rozycki, Martin, Abdullah, Kalil G., Nasrallah, MacLean P., Binder, Zev A., Davuluri, Ramana V., Lustig, Robert A., Dahmane, Nadia, Bilello, Michel, O’Rourke, Donald M., Davatzikos, Christos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865162/ https://www.ncbi.nlm.nih.gov/pubmed/29572492 http://dx.doi.org/10.1038/s41598-018-22739-2

Ejemplares similares

Multivariate Analysis of Preoperative Magnetic Resonance Imaging Reveals Transcriptomic Classification of de novo Glioblastoma Patients
por: Rathore, Saima, et al.
Publicado: (2019)

Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma
por: Fathi Kazerooni, Anahita, et al.
Publicado: (2022)

Multi-institutional noninvasive in vivo characterization of IDH, 1p/19q, and EGFRvIII in glioma using neuro-Cancer Imaging Phenomics Toolkit (neuro-CaPTk)
por: Rathore, Saima, et al.
Publicado: (2021)

MRI-Based Radiomics Combined with Deep Learning for Distinguishing IDH-Mutant WHO Grade 4 Astrocytomas from IDH-Wild-Type Glioblastomas
por: Hosseini, Seyyed Ali, et al.
Publicado: (2023)

The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics
por: Bakas, Spyridon, et al.
Publicado: (2022)

2137 Percentage of viable tumor Versus radiation treatment effect in surgical specimens is not associated with outcomes in recurrent glioblastoma
por: Schwab, Robert D., et al.
Publicado: (2018)

Advancing The Cancer Genome Atlas glioma MRI collections with expert segmentation labels and radiomic features
por: Bakas, Spyridon, et al.
Publicado: (2017)

Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma
por: Fathi Kazerooni, Anahita, et al.
Publicado: (2020)

Applications of Radiomics and Radiogenomics in High-Grade Gliomas in the Era of Precision Medicine
por: Fathi Kazerooni, Anahita, et al.
Publicado: (2021)

Rapid and ultrasensitive digital PCR (dPCR) profiling of EGFRvIII in tumor cells and tissues
por: Saxena, Deeksha, et al.
Publicado: (2019)

Population-based MRI atlases of spatial distribution are specific to patient and tumor characteristics in glioblastoma
por: Bilello, Michel, et al.
Publicado: (2016)

Arterial Spin Labeling and Dynamic Susceptibility Contrast-enhanced MR Imaging for evaluation of arteriovenous shunting and tumor hypoxia in glioblastoma
por: Nabavizadeh, S. Ali, et al.
Publicado: (2019)

Clinical Evaluation of IDH Mutation Status in Formalin-Fixed Paraffin-Embedded Tissue in Gliomas
por: Nelson, Ernest J., et al.
Publicado: (2023)

Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastoma
por: Bagley, Stephen J, et al.
Publicado: (2021)

Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes
por: Pal, Sharmistha, et al.
Publicado: (2014)

Predicting IDH genotype in gliomas using FET PET radiomics
por: Lohmann, Philipp, et al.
Publicado: (2018)

IDH mutation-specific radiomic signature in lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2019)

Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma
por: Nasrallah, MacLean P., et al.
Publicado: (2019)

Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma
por: Makhlin, Igor, et al.
Publicado: (2019)

Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma
por: Durgin, Joseph S., et al.
Publicado: (2021)

IDH3α regulates one-carbon metabolism in glioblastoma
por: May, Jasmine L., et al.
Publicado: (2019)

Multicenter DSC–MRI-Based Radiomics Predict IDH Mutation in Gliomas
por: Manikis, Georgios C., et al.
Publicado: (2021)

Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma
por: Nabavizadeh, Seyed Ali, et al.
Publicado: (2020)

Non-invasive detection of 2-hydroxyglutarate in IDH-mutated gliomas using two-dimensional localized correlation spectroscopy (2D L-COSY) at 7 Tesla
por: Verma, Gaurav, et al.
Publicado: (2016)

The Value of Enhanced MR Radiomics in Estimating the IDH1 Genotype in High-Grade Gliomas
por: Niu, Lei, et al.
Publicado: (2020)

Forecasting Molecular Features in IDH-Wildtype Gliomas: The State of the Art of Radiomics Applied to Neurosurgery
por: Gerardi, Rosa Maria, et al.
Publicado: (2023)

Immune landscapes associated with different glioblastoma molecular subtypes
por: Martinez-Lage, Maria, et al.
Publicado: (2019)

Segmentation and Grade Prediction of Colon Cancer Digital Pathology Images Across Multiple Institutions
por: Rathore, Saima, et al.
Publicado: (2019)

BIMG-12. [18F]FLUCICLOVINE PET TO DISTINGUISH PSEUDOPROGRESSION FROM TUMOR PROGRESSION IN POST-TREATMENT GLIOBLASTOMA
por: Nabavizadeh, Ali, et al.
Publicado: (2021)

Investigating the value of radiomics stemming from DSC quantitative biomarkers in IDH mutation prediction in gliomas
por: Ioannidis, Georgios S., et al.
Publicado: (2023)

A dual-genotype oligoastrocytoma with histologic, molecular, radiological and time-course features
por: Nasrallah, Mac Lean P., et al.
Publicado: (2020)

Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma
por: Richardson, Timothy E, et al.
Publicado: (2023)

Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis
por: Li, Yurong, et al.
Publicado: (2022)

Biological underpinnings of radiomic magnetic resonance imaging phenotypes for risk stratification in IDH wild-type glioblastoma
por: Guan, Fangzhan, et al.
Publicado: (2023)

NPEBseq: nonparametric empirical bayesian-based procedure for differential expression analysis of RNA-seq data
por: Bi, Yingtao, et al.
Publicado: (2013)

Predicting pediatric optic pathway glioma progression using advanced magnetic resonance image analysis and machine learning
por: Pisapia, Jared M, et al.
Publicado: (2020)

Three‐dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma
por: Verma, Gaurav, et al.
Publicado: (2018)

(18)F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling
por: Henderson, Fraser, et al.
Publicado: (2020)

Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas
por: de Godoy, Laiz Laura, et al.
Publicado: (2023)

Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma
por: Li, Zhi‐Cheng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_il0edur15ndhtvecbovpoaf7ec